Use of Rituximab in Pemphigus Vulgaris/Foliaceus Patients During COVID-19 Pandemic

Aparício Martins, ICabete, J2023-03-082023-03-082022Port J Dermatol and Venereol. 2022;80(4):330-331http://hdl.handle.net/10400.17/4443engHSAC DERPandemicsCOVID-19RituximabUse of Rituximab in Pemphigus Vulgaris/Foliaceus Patients During COVID-19 PandemicUtilização de Rituximab em Doentes com Pênfigo Vulgar/Foliáceo Durante a Pandemia COVID-19journal article10.24875/PJDV.22000012